Nelligan William 4
4 · IMS HEALTH INC · Filed Mar 2, 2010
Insider Transaction Report
Form 4
Nelligan William
President, IMS Americas
Transactions
- Award
Common Stock
2010-02-26+27,185→ 61,530 total - Disposition to Issuer
Common Stock
2010-02-26−61,530→ 0 total - Disposition to Issuer
Stock Appreciation Right
2010-02-26−68,681→ 0 totalExercise: $13.43Exp: 2016-04-21→ Common Stock (68,681 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2010-02-26−50,000→ 0 totalExercise: $16.05Exp: 2010-05-20→ Common Stock (50,000 underlying)
Footnotes (6)
- [F1]Grant of Restricted Stock Units for no cash consideration in a transaction exempt under Rule 16b-3.
- [F2]Disposition pursuant to a merger for cash consideration equal to $22.00 per share. This transaction is exempt under Rule 16b-3(e).
- [F3]Such Option became exercisable in three equal installments beginning on 5/20/2004.
- [F4]Option canceled pursuant to a merger in exchange for cash consideration equal to the difference between $22.00 and the exercise price of the Option multiplied by the number of Options canceled. This transaction is exempt under Rule 16b-3(e).
- [F5]Such Stock Appreciation Right will become exercisable in three equal installments beginning on 4/21/2010.
- [F6]Stock Appreciation Rights canceled pursuant to a merger in exchange for cash consideration equal to the difference between $22.00 and the exercise price of the Stock Appreciation Right multiplied by the number canceled. A portion of the Stock Appreciation Rights canceled pursuant to a merger were exchanged for Stock Appreciation Rights in Healthcare Technology Holdings, Inc. The replacement award has an intrinsic value equal to that of the canceled award which is $199,998 based on the merger consideration of $22.00 per share. This transaction is exempt under Rule 16b-3(e).